v3.26.1
Segment Information - Schedule of Revenue, Significant Expenses, and Net (Loss) Income (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Significant and Other Segment Expenses        
General and Administrative $ 1,383,504 $ 1,353,850 $ 2,995,771 $ 2,843,248
Research and Development 2,077,116 2,590,489 4,200,841 5,122,376
KIO-301 Collaboration Credit (1,336,263) (1,685,917) (2,569,487) (3,652,040)
Change in Fair Value of Contingent Consideration 89,414 137,774 96,841 412,966
Income Tax Provision 0 (112,057) 0 10,949
Net Loss (2,079,010) (2,152,459) (4,496,994) (4,345,439)
Reportable Segment        
Significant and Other Segment Expenses        
General and Administrative 1,383,504 1,353,850 2,995,771 2,843,248
Research and Development 2,077,116 2,590,489 4,200,841 5,122,377
KIO-301 Collaboration Credit (1,336,263) (1,685,917) (2,569,487) (3,652,040)
Change in Fair Value of Contingent Consideration 89,414 137,774 96,841 412,966
Interest Income, Net (146,232) (225,237) (285,570) (397,703)
Other Segment Expenses 10,672 93,556 57,798 5,642
Income Tax Provision 800 (112,057) 800 10,949
Net Loss (2,079,011) (2,152,459) (4,496,994) (4,345,439)
KIO-101 | Reportable Segment        
Significant and Other Segment Expenses        
Research and Development 0 3,780 0 6,795
KIO-104 | Reportable Segment        
Significant and Other Segment Expenses        
Research and Development 267,155 426,347 554,164 277,022
KIO-301 | Reportable Segment        
Significant and Other Segment Expenses        
Research and Development 1,748,759 2,125,633 3,308,866 4,227,484
Unallocated R&D Expenses | Reportable Segment        
Significant and Other Segment Expenses        
Research and Development $ 61,202 $ 34,729 $ 337,811 $ 611,076